BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25801334)

  • 1. Significance of FBX8 in progression of gastric cancer.
    Wu P; Wang F; Wang Y; Men H; Zhu X; He G; Ma W; Xin S; Wu J; Liao W; Ding Y; He M; Liang L
    Exp Mol Pathol; 2015 Jun; 98(3):360-6. PubMed ID: 25801334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma.
    Wang F; Qiao Y; Yu J; Ren X; Wang J; Ding Y; Zhang X; Ma W; Ding Y; Liang L
    PLoS One; 2013; 8(6):e65495. PubMed ID: 23826080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBX8 degrades GSTP1 through ubiquitination to suppress colorectal cancer progression.
    FeiFei W; HongHai X; YongRong Y; PingXiang W; JianHua W; XiaoHui Z; JiaoYing L; JingBo S; Kun Z; XiaoLi R; Lu Q; XiaoLiang L; ZhiQiang C; Na T; WenTing L; YanQing D; Li L
    Cell Death Dis; 2019 Apr; 10(5):351. PubMed ID: 31024008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-expression of F box only protein 8 correlates with tumor grade and poor prognosis in human glioma.
    Yu Y; Sun L; Ren N; Li Y; Rong L; Zhao G
    Int J Clin Exp Pathol; 2014; 7(11):8071-6. PubMed ID: 25550853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBX8 is a metastasis suppressor downstream of miR-223 and targeting mTOR for degradation in colorectal carcinoma.
    Wang FF; Zhang XJ; Yan YR; Zhu XH; Yu J; Ding Y; Hu JL; Zhou WJ; Zeng ZC; Liao WT; Ding YQ; Liang L
    Cancer Lett; 2017 Mar; 388():85-95. PubMed ID: 27916606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
    Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
    Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
    Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
    J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FBX8 promotes metastatic dormancy of colorectal cancer in liver.
    Zhu X; Wang F; Wu X; Li Z; Wang Z; Ren X; Zhou Y; Song F; Liang Y; Zeng Z; Liao W; Ding Y; Liao W; Liang L
    Cell Death Dis; 2020 Aug; 11(8):622. PubMed ID: 32796813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Liu Q
    J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
    Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
    Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer.
    Zhang J; Zhu Z; Sheng J; Yu Z; Yao B; Huang K; Zhou L; Qiu Z; Huang C
    Oncotarget; 2017 May; 8(21):34867-34883. PubMed ID: 28432273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
    Liu L; Tian YC; Mao G; Zhang YG; Han L
    Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
    J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen‑like‑protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
    Zhang Y; Qiao HX; Zhou YT; Hong L; Chen JH
    Mol Med Rep; 2018 Aug; 18(2):1465-1472. PubMed ID: 29845203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
    Ge F; Wang C; Wang W; Liu W; Wu B
    Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-665 is down-regulated in gastric cancer and inhibits proliferation, invasion, and EMT by targeting PPP2R2A.
    Zhang M; Wang S; Yi A; Qiao Y
    Cell Biochem Funct; 2020 Jun; 38(4):409-418. PubMed ID: 31923339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA-MEG3 inhibits proliferation and metastasis by regulating miRNA-21 in gastric cancer.
    Dan J; Wang J; Wang Y; Zhu M; Yang X; Peng Z; Jiang H; Chen L
    Biomed Pharmacother; 2018 Mar; 99():931-938. PubMed ID: 29710493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
    Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y
    Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.